Beovu
Total Payments
$2.1M
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $2.1M | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.1M | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| RESEARCH RELATED TO Beovu | NOVARTIS PHARMACEUTICALS CORPORATION | $2.1M | 0 |
Top Doctors Receiving Payments for Beovu
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cleveland, OH | $2.1M | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $2.1M
- Total Doctors 0
- Transactions 1
About Beovu
Beovu is a drug associated with $2.1M in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is NOVARTIS PHARMACEUTICALS CORPORATION.
Payment data is available from 2020 to 2020. In 2020, $2.1M was paid across 1 transactions to 0 doctors.
The most common payment nature for Beovu is "Unspecified" ($2.1M, 100.0% of total).
Beovu is associated with 1 research study, including "RESEARCH RELATED TO Beovu" ($2.1M).